Source: International Congress 2015 – The multiple faces of host defense
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Vencken (Dublin, Ireland), Sebastian Vencken, Irene Oglesby, Raman Agrawal, Kevin Gaughan, Gerry McElvaney, Marcus Mall, Catherine Greene. Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis. Eur Respir J 2015; 46: Suppl. 59, 1783

Member's Comments

No comment yet.

Related content which might interest you: MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 microRNA-mediated inhibition of IL-8 production from cystic fibrosis bronchial epithelial cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Effect of pirfenidone on TGF-beta-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 CFTR regulation by microRNA-145, -223 and -494 is altered in deltaF508 cystic fibrosis airway epithelium Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Role of Wnt-1, Wnt-3 and MMP-7 in fibrotic response in extrinsic allergic alveolitis and idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 Severe lung inflammation is a feature of IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Dasatinib suppresses TGFbeta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Role of MUC1 in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation Source: International Congress 2014 – Cell biology 2014 Year: 2014 Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling Source: International Congress 2014 – ILDs 4 Year: 2014 Dissecting the role of TRPC6-channels in bleomycin-induced pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Inflammatory biomarkers in urine of cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Antiviral activity of azithromycin in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Airway epithelial cell IP-10 production is regulated by miR-31 via the transcription factor IRF-1 Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002